Ricci, 52 patient vitamin D sufficiency study: 88% lower mortality [p=0.07] https://c19p.org/ricci
copied to clipboard
Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients
et al., Respiratory Research, doi:10.1186/s12931-021-01666-3
Retrospective 52 hospitalized COVID-19 patients showing that vitamin D deficiency is associated with compromised inflammatory responses and higher pulmonary involvement. Vitamin D deficient patients also showed higher mortality, although not quite reaching statistical significance with the small sample size.
|
risk of death, 87.6% lower, RR 0.12, p = 0.07, high D levels 0 of 30 (0.0%), low D levels 3 of 22 (13.6%), NNT 7.3, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), >10 ng/mL.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Ricci et al., 3/3/2021, retrospective, Italy, Europe, peer-reviewed, 15 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.